Neuralstem’s Preclinical Alzheimer’s Disease Data Published In Stem Cells … – PR Newswire (press release)
|
Neuralstem's Preclinical Alzheimer's Disease Data Published In Stem Cells …
PR Newswire (press release) GERMANTOWN, Md., Jan. 11, 2016 /PRNewswire/ — Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced … |
